MyFinsight
Home
Blog
About
Contact
Cash
$3,250,650
Other prepaid
expenses
$101,069
Prepaid insurance
$56,031
Light proton therapy
system equipment
$6,607,419
Total current assets
$3,407,750
Operating lease
right-of-use assets
$850,129
Total assets
$10,865,298
Total liabilities and
stockholders equity
$10,865,298
Total stockholders
equity
$9,178,592
Total liabilities
$1,686,706
Total lixte
biotechnology stockholders...
$7,945,032
Non-controlling interest
$1,233,560
Total current
liabilities
$1,224,934
Operating lease
obligations, long-term
$461,772
Accumulated deficit
-$60,000,889
Additional paid-in capital
$67,944,759
Operating lease
obligations, current
$595,418
Related parties
accounts payable and...
$391,081
Research and development
contract liabilities
$238,435
Common stock, 0.0001
par value...
$1,162
Back
Back
Balance Sheet
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
source: myfinsight.com